Jane Street
PCRX icon

Jane Street’s Pacira BioSciences PCRX Stock Holding History

Jane Street’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,800
Closed -$1.26M – 11519
2025
Q2 		$1.26M Sell
52,800
-9,700
-16% -$245K ﹤0.01% 5190
2025
Q1 		$1.55M Buy
+62,500
New +$1.5M ﹤0.01% 4785
2023
Q3 		– Sell
-40,000
Closed -$1.6M – 9178
2023
Q2 		$1.6M Sell
40,000
-200
-0.5% -$8.27K ﹤0.01% 4495
2023
Q1 		$1.64M Buy
40,200
+4,200
+12% +$167K ﹤0.01% 4161
2022
Q4 		$1.39M Buy
36,000
+20,100
+126% +$978K ﹤0.01% 4453
2022
Q3 		$846K Sell
15,900
-15,800
-50% -$879K ﹤0.01% 5721
2022
Q2 		$1.85M Sell
31,700
-17,600
-36% -$1.15M ﹤0.01% 4317
2022
Q1 		$3.76M Buy
49,300
+37,300
+311% +$2.49M ﹤0.01% 3524
2021
Q4 		$722K Buy
12,000
+6,100
+103% +$336K ﹤0.01% 6577
2021
Q3 		$330K Sell
5,900
-7,800
-57% -$450K ﹤0.01% 8003
2021
Q2 		$831K Buy
+13,700
New +$867K ﹤0.01% 6228
2021
Q1 		– Sell
-5,600
Closed -$335K – 9460
2020
Q4 		$335K Buy
+5,600
New +$328K ﹤0.01% 6262
2019
Q4 		– Sell
-8,000
Closed -$305K – 5560
2019
Q3 		$305K Buy
+8,000
New +$319K ﹤0.01% 4169
2018
Q4 		– Sell
-16,400
Closed -$806K – 5498
2018
Q3 		$806K Sell
16,400
-500
-3% -$21.6K ﹤0.01% 3035
2018
Q2 		$542K Buy
+16,900
New +$583K ﹤0.01% 3505
2017
Q1 		– Sell
-10,000
Closed -$323K – 4544
2016
Q4 		$323K Hold
10,000
– – ﹤0.01% 3287
2016
Q3 		$342K Buy
+10,000
New +$392K ﹤0.01% 3167

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's PCRX Position: Q2 2026 in Review

Jane Street sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 140,247 shares — an estimated $3.32M sold.

Jane Street first reported a position in PCRX in Q1 2014 and held it in 38 quarters. The position peaked at $9.99M in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Jane Street reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 140,247 Pacira BioSciences shares in Q2 2026, an estimated $3.32M.
  • Jane Street first reported a position in Pacira BioSciences in Q1 2014 and held it in 38 quarters.
  • Jane Street's Pacira BioSciences position peaked at $9.99M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.